PCT/CA2014/050273

DETECTION AND QUANTIFICATION OF ACETYLAMANTADINE IN URINE SAMPLES

Details for PCT/CA2014/050273

Application No.

PCT Application Number

PCT/CA/2014/050273

Publication No.

PCT Publication Number

WO/2014/139025

Applicants

PCT Patent Applicants

BIOMARK TECHNOLOGIES INC.

Agents

PCT Patent Agents

CAMERON IP

Priority Data

PCT Patent Priority Data

US61/785,159 filed on March 14, 2013

PCT Pamphlet

The front page of the PCT Patent Application

PCT Pamphlet Front Page

Dates

Application Date

March 14, 2014

Publication Date

September 18, 2014

Earliest Priority Date

March 14, 2013

Deadlines

30 Month Date

30 Month National Phase Deadline.

September 14, 2015

31 Month Date

31 Month National Phase Deadline.

October 14, 2015

These dates are in the Past. Contact us to find out if National Phase entry is still possible.

Abstract

A method for quantifying acetylamantadine in a urine sample comprises eluting acetylamantadine from the urine sample using solid phase extraction and quantifying the acetylamantadine eluted from the urine sample using Raman spectroscopy.

Info

PCT Patent application PCT/CA2014/050273 was filed on March 14, 2014 by BIOMARK TECHNOLOGIES INC.. The title of this PCT Patent Application is "DETECTION AND QUANTIFICATION OF ACETYLAMANTADINE IN URINE SAMPLES" and the patent specification was published as WO/2014/139025 on September 18, 2014.

The earliest priority date for the patent application is March 14, 2013 and therefore the 30 month national phase deadline for PCT/CA/2014/050273 is September 14, 2015 and the 31 month national phase deadline for PCT/CA/2014/050273 is October 14, 2015

Legal

The information provided herein is not legal or other professional advice. The information herein may be provided from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein.